American International Group’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

American International Group’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-23,650	Closed	-$9K	–	4949
2016 Q1	$9K	Hold	23,650	–	–	﹤0.01%	4605
2015 Q4	$9K	Hold	23,650	–	–	﹤0.01%	4562
2015 Q3	$14K	Hold	23,650	–	–	﹤0.01%	4408
2015 Q2	$12.8K	Hold	23,650	–	–	﹤0.01%	4516
2015 Q1	$19.3K	Sell	23,650 -3,700	-14%	-$3.05K	﹤0.01%	4349
2014 Q4	$21.9K	Hold	27,350	–	–	﹤0.01%	4301
2014 Q3	$27.9K	Hold	27,350	–	–	﹤0.01%	4213
2014 Q2	$23.5K	Buy	+27,350	New	+$32.8K	﹤0.01%	4237

Other funds holding PVCT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HFBOT

Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return

American International Group's PVCT Position: Q2 2016 in Review

American International Group sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q2 2016, closing a stake of 23,650 shares — an estimated $9K sold.

American International Group first reported a position in PVCT in Q2 2014 and held it in 8 quarters. The position peaked at $27.9K in Q3 2014. 45 funds tracked by Wall St. Rank hold PVCT as of Q2 2016.

American International Group reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q2 2016 after selling out during the quarter.
American International Group sold 23,650 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q2 2016, an estimated $9K.
American International Group first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q2 2014 and held it in 8 quarters.
American International Group's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $27.9K in Q3 2014.
45 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.